Akso Health Group ADR (AHG)vsHenry Schein Inc (HSIC)
AHG
Akso Health Group ADR
$0.75
-1.32%
HEALTHCARE · Cap: $634.05M
HSIC
Henry Schein Inc
$86.37
+0.98%
HEALTHCARE · Cap: $9.50B
Smart Verdict
WallStSmart Research — data-driven comparison
Henry Schein Inc generates 98238% more annual revenue ($13.60B vs $13.83M). HSIC leads profitability with a 3.0% profit margin vs -135.0%. HSIC earns a higher WallStSmart Score of 56/100 (C).
AHG
Avoid15
out of 100
Grade: F
HSIC
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+10.2%
Fair Value
$1.57
Current Price
$0.75
$0.82 discount
Margin of Safety
+47.6%
Fair Value
$156.00
Current Price
$86.37
$69.63 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -89.4% — below average capital efficiency
Revenue declined 12.9%
Expensive relative to growth rate
3.0% margin — thin
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.
Bull Case : HSIC
HSIC has a balanced fundamental profile.
Bear Case : AHG
The primary concerns for AHG are EPS Growth, Market Cap, Return on Equity.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, Profit Margin, Debt/Equity. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
AHG profiles as a turnaround stock while HSIC is a value play — different risk/reward profiles.
HSIC carries more volatility with a beta of 0.81 — expect wider price swings.
HSIC is growing revenue faster at 6.7% — sustainability is the question.
HSIC generates stronger free cash flow (196M), providing more financial flexibility.
Bottom Line
HSIC scores higher overall (56/100 vs 15/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.
Visit Website →Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?